Well Lead Med Co Ltd (603309) — Capital Reinvestment Ratio

Latest as of September 2025: 0.49x

Well Lead Med Co Ltd (603309) has a Capital Reinvestment Ratio of 0.49x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥126.26 Million) in capital expenditures (CN¥62.08 Million). See Well Lead Med Co Ltd (603309) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.49x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥126.26 Million
CNY

Capital Expenditures

CN¥62.08 Million
CNY

Data as of

Sep 2025
Most recent filing

Well Lead Med Co Ltd Capital Reinvestment Ratio (2011–2024)

This chart tracks Well Lead Med Co Ltd's Capital Reinvestment Ratio across 14 annual periods.

Annual Capital Reinvestment Ratio for Well Lead Med Co Ltd (2011–2024)

Year-by-year Capital Reinvestment Ratio for Well Lead Med Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see Well Lead Med Co Ltd stock valuation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 1.03x CN¥306.26 Million CN¥315.73 Million ▼ -32.7%
2023 1.53x CN¥233.51 Million CN¥357.89 Million ▲ +230.5%
2022 0.46x CN¥391.13 Million CN¥181.38 Million ▼ -20.5%
2021 0.58x CN¥187.28 Million CN¥109.28 Million ▲ +44.1%
2020 0.40x CN¥228.44 Million CN¥92.49 Million ▼ -35.7%
2019 0.63x CN¥178.79 Million CN¥112.54 Million ▼ -28.1%
2018 0.88x CN¥89.89 Million CN¥78.66 Million ▼ -8.5%
2017 0.96x CN¥74.34 Million CN¥71.12 Million ▲ +18.4%
2016 0.81x CN¥85.35 Million CN¥68.93 Million ▲ +77.9%
2015 0.45x CN¥81.47 Million CN¥36.98 Million ▼ -5.4%
2014 0.48x CN¥107.34 Million CN¥51.49 Million ▼ -18.9%
2013 0.59x CN¥72.85 Million CN¥43.06 Million ▲ +4.9%
2012 0.56x CN¥83.23 Million CN¥46.92 Million ▼ -44.5%
2011 1.02x CN¥44.08 Million CN¥44.77 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow